CHA Vaccine Research Institute Co Ltd
261780
Company Profile
Business description
CHA Vaccine Research Institute Co Ltd is a research-oriented biotechnology company. It researches and develops a broad range of vaccine products targeting infectious disease as well as chronic disease.
Contact
560 Dunchon-daero, Jungwon-gu
Gyeonggi-do
Seongnam-si13230
KORT: +82 31737820
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
51
Stocks News & Analysis
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.
stocks
ASX energy share remains cheap despite strong outlook
Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.
stocks
Moated AI-proof tech play hiding in the ASX 100
ChatGPT and large language models should be a tailwind for this company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,001.60 | 23.80 | -0.26% |
| CAC 40 | 8,227.32 | 70.89 | 0.87% |
| DAX 40 | 24,155.45 | 39.45 | -0.16% |
| Dow JONES (US) | 49,310.32 | 179.71 | -0.36% |
| FTSE 100 | 10,457.01 | 19.45 | -0.19% |
| HKSE | 25,899.89 | 15.31 | -0.06% |
| NASDAQ | 24,438.50 | 219.06 | -0.89% |
| Nikkei 225 | 59,665.94 | 525.71 | 0.89% |
| NZX 50 Index | 12,874.94 | 9.99 | -0.08% |
| S&P 500 | 7,108.40 | 29.50 | -0.41% |
| S&P/ASX 200 | 8,781.50 | 17.10 | -0.19% |
| SSE Composite Index | 4,077.96 | 15.29 | -0.37% |